Recent human studies have shown that serum ANGPTL8 levels are increased in subjects with Type 1 diabetes (T1D)12, obesity13, Type 2 diabetes (T2D)13–15, and non-alcoholic fatty liver disease (NAFLD)16. Here, ANGPTL8 is linked to metabolic dysfunction-associated steatotic liver disease.